Lilly Stock Jumps After Phase 3 Weight-Drug Readout
Lilly stock jumps after Phase 3 readout for a next-generation weight-loss drug exceeded expectations. Investors see d...
Choosing the right retirement plan is vital for meeting your financial goals. Explore various plans to find the best fit for you.
25,495 articlesLilly stock jumps after Phase 3 readout for a next-generation weight-loss drug exceeded expectations. Investors see d...
A provocative forecast from Elon Musk about AI-driven code creation is sending ripples through tech equities and hiri...
A broad coalition urges the Senate to take up the CLARITY Act, intensifying the fight over crypto regulation even as ...
Palantir emphasizes software-driven AI workflows with an asset-light model, while Oracle bets on cloud-scale GPU depl...
Visa’s CFO signaled that stablecoins and agentic commerce are not material to near-term growth, as the payments giant...
Anthropic’s Claude Code chief reveals three hiring traits—generalist thinking, humility, and data-driven iteration—as...
Nightrush.com announces a major editorial and platform revamp to match AI-driven personalization in iGaming, with a f...
ADA sinks to multi-year lows as large holders pull profits and reallocate. Traders weigh whether the rout signals cap...
Bitcoin nears realized price, but the telltale capitulation signs critics expect are missing, leaving traders debatin...
As a new Fed leadership team takes the reins, investors are bracing for a steadier communications stance. Analysts sa...
June 2026 shifts spotlight to Tesla and BYD as margin rebound meets policy tailwinds. Here’s the latest data and what...
Tokens tied to Venice and Morpheus surged after a U.S. regulatory move targeting Anthropic’s Fable 5, highlighting a ...